Pharmaceutical company, Warner Chilcott, has announced a 42 per cent improvement in its net losses in the fist nine months of this year. The company, which sells and markets cholesterol and acne products, reported net losses of $19.9 million (£13.3 million) compared with $34.1 million in the same period last year. It is quoted on the Nasdaq market.

The company, which is 30 per cent owned by Elan, employs two people in Dublin.